1.97 USD
↗ 0.08 (4.23%)AT CLOSE (11:59 AM EDT)
Palisade Bio, Inc. Common Stock
PALINASDAQ • USD
1.97
↗ 0.00 (0.00%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
1.97
↗ 0.00 (0.00%)
Market: CLOSED
Palisade Bio, Inc. Common Stock (PALI) trades at $1.97 per share. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, PALI appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jul 17, 2026.
Open?$1.86
High?$2.03
Low?$1.84
Prev. Close?$1.89
Volume?2.1M
Avg. Volume?4.0M
VWAP?$1.97
Rel. Volume?0.53x
Bid / Ask
Bid?$1.91 × 5.0K
Ask?$2.03 × 600
Spread?$0.12
Midpoint?$1.97
Valuation & Ratios
Market Cap?342.3M
Shares Out?173.6M
Float?165.0M
Float %?99.4%
P/E Ratio?N/A
P/B Ratio?2.69
EPS?-$0.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Employees
14
Market Cap
328.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-04-28
Address
7750 EL CAMINO REAL, SUITE 5200
CARLSBAD, CA 92009
Phone: (858) 704-4900
CARLSBAD, CA 92009
Phone: (858) 704-4900
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?31
Piotroski F-Score?0/9Weak
Altman Z-Score?33.29Safe
Confidence?45%Low
Short InterestHigh
Short % of Float?19.48%High
Short Interest?32.1M
Days to Cover?5.4
Free Float165.0M
Avg Daily Volume6.0M
Settlement Date2026-06-30
Financial Health
Current Ratio?23.71Strong
Quick Ratio?23.71Strong
Cash Ratio?23.60Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.69CHEAP▾
Peers100
S&P61
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-7.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-19.0%WEAK▾
S&P8
ROA?-18.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$209.7M
Fundamentals ratios updated end of day